ArticleBioengineering (Basel, Switzerland)2025
DermViT: Diagnosis-Guided Vision Transformer for Robust and Efficient Skin Lesion Classification.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A Reproducible and Explainable Deep Learning Framework for Dermoscopic Image Analysis in Skin Cancer.Journal of clinical medicine · 2026Article
- Interpretable Skin Cancer Identification Using a Hybrid Deep Learning and XAI Framework on HAM10000.Bioengineering (Basel, Switzerland) · 2026Article
- SkinFormer: a hybrid vision transformer and ConvNeXtV2 approach for skin cancer detection and segmentation.Scientific reports · 2026Article
- Multimodal artificial intelligence for enhanced skin cancer diagnosis and prognosis.Discover oncology · 2026Review
- Quantum-enhanced multimodal prognostic transformer for skin disease progression prediction and visualization.Scientific reports · 2026Article
- Transformer-Based Foundation Learning for Robust and Data-Efficient Skin Disease Imaging.Diagnostics (Basel, Switzerland) · 2026Article
- Vision transformer-based uncertainty quantification for triaging skin lesions: a probabilistic framework for automated biopsy recommendation.Frontiers in bioengineering and biotechnology · 2026Article
- Machine learning-based adaptive personalization in virtual reality stroke rehabilitation: a systematic review.Frontiers in rehabilitation sciences · 2026Review
- Artificial Intelligence and New Technologies in Melanoma Diagnosis: A Narrative Review.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Early diagnosis of skin cancer can significantly improve patient survival. Currently, skin lesion classification faces challenges such as lesion-background semantic entanglement, high intra-class variability, artifactual interference, and more, while existing classification models lack modeling of physicians' diagnostic paradigms. To this end, we propose DermViT, a medically driven deep learning architecture that addresses the above issues through a medically-inspired modular design. DermViT consists of three main modules: (1) Dermoscopic Context Pyramid (DCP), which mimics the multi-scale observation process of pathological diagnosis to adapt to the high intraclass variability of lesions such as melanoma, then extract stable and consistent data at different scales; (2) Dermoscopic Hierarchical Attention (DHA), which can reduce computational complexity while realizing intelligent focusing on lesion areas through a coarse screening-fine inspection mechanism; (3). Dermoscopic Feature Gate (DFG), which simulates the observation-verification operation of doctors through a convolutional gating mechanism and effectively suppresses semantic leakage of artifact regions. Our experimental results show that DermViT significantly outperforms existing methods in terms of classification accuracy (86.12%, a 7.8% improvement over ViT-Base) and number of parameters (40% less than ViT-Base) on the ISIC2018 and ISIC2019 datasets. Our visualization results further validate DermViT's ability to locate lesions under interference conditions. By introducing a modular design that mimics a physician's observation mode, DermViT achieves more logical feature extraction and decision-making processes for medical diagnosis, providing an efficient and reliable solution for dermoscopic image analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.